Adjuvant Radiotherapy for Dissected Parotid Lymph Nodes Containing Merkel Cell Carcinoma from an Unknown Primary Skin Site: 2 Case Reports
American Journal of Case Reports · 2023
DOI: 10.12659/ajcr.939183 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Case Reports, 2023. Verfasst von Tzu-Yun Lai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tungs' Taichung MetroHarbor General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Neoplasms, Unknown Primary, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Merkel cell carcinoma (MCC) is an aggressive neuroendocrine malignancy that has increased in incidence in recent decades. The management of MCC should involve multidisciplinary experts to achieve optimal patient outcomes. Radiotherapy is commonly used as adjuvant therapy. Our literature review of MCC indicates that aggressive adjuvant radiotherapy might have a positive impact on overall local control and survival. CASE REPORT The first case is a 75-year-old male patient who discovered a right preauricular mass 2 weeks prior. He underwent right parotidectomy with tumor removal on 2012/07/09, and pathology revealed MCC in 3 lymph nodes. The patient received postoperative adjuvant radiotherapy (61.2 Gy) to the remaining right parotid tumor bed and right neck lymph nodes. The patient refused adjuvant chemotherapy. During long-term follow-up, the patient remained disease free for 10 years. The other case is a 73-year-old female patient with metastatic MCC in a left parotid lymph node. She also underwent left parotidectomy with tumor removal, and pathological staging performed according to the 8th edition of the AJCC staging system showed pTxN1aMx, stage IIIA. After the operation, she received postoperative adjuvant radiotherapy (56 Gy) to the remaining left parotid and left neck lymph nodes. The patient remained disease free for 14 months. CONCLUSIONS Metastatic MCC of the parotid lymph nodes without a detectable primary skin tumor is very rare. Adjuvant radiotherapy to the tumor bed and regional nodal basin might be beneficial for preventing disease recurrence despite the absence of systemic medical therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Tungs' Taichung MetroHarbor General Hospital, Taichung, Taiwan.
ORCID-Profile: Chi-Yuan Peter Yeh
Zitieren
APA
Lai, T. Y., Liu, F. H., Lai, P. A., & Yeh, C. P. (2023). Adjuvant Radiotherapy for Dissected Parotid Lymph Nodes Containing Merkel Cell Carcinoma from an Unknown Primary Skin Site: 2 Case Reports. American Journal of Case Reports. https://doi.org/10.12659/ajcr.939183
Vancouver
Lai TY, Liu FH, Lai PA, Yeh CP. Adjuvant Radiotherapy for Dissected Parotid Lymph Nodes Containing Merkel Cell Carcinoma from an Unknown Primary Skin Site: 2 Case Reports. American Journal of Case Reports. 2023. doi:10.12659/ajcr.939183
BibTeX
@article{Lai2023,
author = {Lai, Tzu-Yun and Liu, Fang-Hui and Lai, Peng-An and Yeh, Chi-Yuan Peter},
title = {Adjuvant Radiotherapy for Dissected Parotid Lymph Nodes Containing Merkel Cell Carcinoma from an Unknown Primary Skin Site: 2 Case Reports},
journal = {American Journal of Case Reports},
year = {2023},
doi = {10.12659/ajcr.939183}
}
EUVIMED